IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Kynam Capital Management, LP

Q2 2025 Holdings

Filed 2025-08-14 | 31 holdings | $928.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Celldex Therapeutics Inc New(CLDX)COM NEW15117B202$124.1M6,100,72913.4%
Vaxcyte Inc(PCVX)COM92243G108$99.9M3,071,58810.8%
Vera Therapeutics Inc(VERA)CL A92337R101$80.7M3,426,8878.7%
Syndax Pharmaceuticals Inc(SNDX)COM87164F105$79.8M8,520,0008.6%
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$75.8M8,463,7428.2%
CG Oncology Inc(CGON)COM156944100$63.9M2,457,6676.9%
Viridian Therapeutics Inc(VRDN)COM92790C104$61.9M4,427,9276.7%
Cogent Biosciences Inc(COGT)COM19240Q201$61.0M8,492,5576.6%
Beam Therapeutics Inc(BEAM)COM07373V105$41.1M2,417,6474.4%
Immunocore Hldgs PLC(IMCR)ADS45258D105$30.6M976,2673.3%
Wave Life Sciences LTD(WVE)SHSY95308105$29.6M4,560,0533.2%
Travere Therapeutics Inc(TVTX)COM89422G107$22.8M1,540,6912.5%
Tyra Biosciences Inc(TYRA)COM90240B106$22.3M2,329,9982.4%
Dynavax Technologies Corp(DVAX)COM NEW268158201$21.3M2,145,3192.3%
Engene Holdings Inc(ENGN)COM29286M105$18.2M4,994,0902.0%
Cullinan Therapeutics Inc(CGEM)COM230031106$15.8M2,095,9981.7%
Nurix Therapeutics Inc(NRIX)COM67080M103$13.4M1,173,6051.4%
Relay Therapeutics Inc(RLAY)COM75943R102$10.0M2,887,0141.1%
Amarin Corp PLC(EH3)SPONSORED ADR023111404$9.3M576,1111.0%
Urogen Pharma LTD(URGN)COMM96088105$9.0M656,5731.0%
Cytomx Therapeutics Inc(CTMX)COM23284F105$4.9M2,154,4130.5%
Geron Corp(GERN)COM374163103$4.9M3,456,3180.5%
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$3.9M5,466,8250.4%
Caribou Biosciences Inc(CRBU)COM142038108$3.9M3,067,7740.4%
Sutro Biopharma IncCOM869367102$3.6M5,088,0990.4%
Design Therapeutics Inc(DSGN)COM25056L103$3.5M1,029,5790.4%
Proqr Thrapeutics N VSHS EURON71542109$3.4M1,649,4620.4%
Edgewise Therapeutics Inc(EWTX)COM28036F105$3.3M253,9790.4%
Burning Rock Biotech LTD(BNR)SPONSORED ADS12233L206$3.1M994,8830.3%
Liquidia Corporation(LQDA)COM NEW53635D202$2.5M200,0470.3%
Climb BIO Inc(CLYM)COM28658R106$1.3M1,028,3410.1%